COVID-19

Development of COVID-19 vaccine

Dengue

Development of nanoparticle-based dengue DNA vaccine

HIV

We have been working on HIV DNA vaccine

HDM Allergy

Development of vaccines for prevention and treatment of HDM allergy

Leptospirosis

Development of subunit vaccines against leptospirosis

Center of Excellence in Vaccine Research and Development,
Chulalongkorn University (Chula VRC)

Chula VRC was formally established in 2017 under the supervision of Professor Kiat Ruxrungtham. We consists of faculty staff and researchers with common interest in vaccine research and development to work together and share their knowledge and experience leading to the strength of the team. We focuses not only on vaccines against infectious diseases, such as HIV infection, dengue fever, leptospirosis, and emerging infections including novel corona virus disease (COVID-19) but also vaccines against non-infectious diseases including house dust mite allergy.


Key Contact Persons

Latest News & Events

December 22, 2023
From https://www.who.int/news-room/events/detail/2023/10/31/default-calendar/who-mpp-regi
November 6, 2023

From: Department of Chemical and Biological Engineering, University of Sheffield Professo

October 9, 2023

Organized by Chula Vaccine and Research Center (Chula VRC)

October 6, 2023

Congratulations to Drew Weissman and Katalin Kariko for the Nobel Prize in Physiology or

September 21, 2023

From: The Independent Panel for Pandemic Preparedness and Response Statement of the Right

Posted in News | Tags:
January 24, 2023

From BioNet-Asia ChulaCov19 BNA159 is a COVID–19 mRNA vaccine developed by Chulalong

June 29, 2022

เปิดรับสมัครอาสาสมัครสุขภาพดีสำหรับโครงการ ChulaCov19 BNA159 mRNA vaccine คุณสมบัติ อายุ

June 9, 2022

A COVID-19 vaccine made by BioNet-Asia in Ayutthaya, Thailand, should be cheaper than the

February 11, 2022

Dr.Chanchai Sittipunt, Dr.Nakorn Premsri, Dr.Suthipong Watcharasin and Dr.Kiat Ruxrungtham greetings to three Prince Mahidol Award 2021 laureates

Posted in News